These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 31504240)

  • 1. CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice.
    Mancuso R; Fryatt G; Cleal M; Obst J; Pipi E; Monzón-Sandoval J; Ribe E; Winchester L; Webber C; Nevado A; Jacobs T; Austin N; Theunis C; Grauwen K; Daniela Ruiz E; Mudher A; Vicente-Rodriguez M; Parker CA; Simmons C; Cash D; Richardson J; ; Jones DNC; Lovestone S; Gómez-Nicola D; Perry VH
    Brain; 2019 Oct; 142(10):3243-3264. PubMed ID: 31504240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A; Schetters ST; Sri S; Askew K; Mancuso R; Vargas-Caballero M; Holscher C; Perry VH; Gomez-Nicola D
    Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.
    Obst J; Simon E; Martin-Estebane M; Pipi E; Barkwill LM; Gonzalez-Rivera I; Buchanan F; Prescott AR; Faust D; Fox S; Brownlees J; Taylor D; Perry VH; Nuthall H; Atkinson PJ; Karran E; Routledge C; Gomez-Nicola D
    Front Immunol; 2020; 11():579000. PubMed ID: 33162994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
    Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
    J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial reduction of microglia does not affect tau pathology in aged mice.
    Bennett RE; Bryant A; Hu M; Robbins AB; Hopp SC; Hyman BT
    J Neuroinflammation; 2018 Nov; 15(1):311. PubMed ID: 30413160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF1R signaling is a regulator of pathogenesis in progressive MS.
    Hagan N; Kane JL; Grover D; Woodworth L; Madore C; Saleh J; Sancho J; Liu J; Li Y; Proto J; Zelic M; Mahan A; Kothe M; Scholte AA; Fitzgerald M; Gisevius B; Haghikia A; Butovsky O; Ofengeim D
    Cell Death Dis; 2020 Oct; 11(10):904. PubMed ID: 33097690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
    Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
    Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice.
    Ruan Z; Delpech JC; Venkatesan Kalavai S; Van Enoo AA; Hu J; Ikezu S; Ikezu T
    Mol Neurodegener; 2020 Aug; 15(1):47. PubMed ID: 32811520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice.
    Dagher NN; Najafi AR; Kayala KM; Elmore MR; White TE; Medeiros R; West BL; Green KN
    J Neuroinflammation; 2015 Aug; 12():139. PubMed ID: 26232154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
    Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
    Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
    Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
    J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease.
    Vicente-Rodríguez M; Mancuso R; Peris-Yague A; Simmons C; ; Gómez-Nicola D; Perry VH; Turkheimer F; Lovestone S; Parker CA; Cash D
    J Neuroinflammation; 2023 Apr; 20(1):92. PubMed ID: 37032328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
    Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
    J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model.
    Spangenberg E; Severson PL; Hohsfield LA; Crapser J; Zhang J; Burton EA; Zhang Y; Spevak W; Lin J; Phan NY; Habets G; Rymar A; Tsang G; Walters J; Nespi M; Singh P; Broome S; Ibrahim P; Zhang C; Bollag G; West BL; Green KN
    Nat Commun; 2019 Aug; 10(1):3758. PubMed ID: 31434879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model.
    Ponnusamy M; Wang S; Yuksel M; Hansen MT; Blazier DM; McMillan JD; Zhang X; Dammer EB; Collier L; Thinakaran G
    Brain; 2023 Apr; 146(4):1561-1579. PubMed ID: 36059072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia regulate hippocampal neurogenesis during chronic neurodegeneration.
    De Lucia C; Rinchon A; Olmos-Alonso A; Riecken K; Fehse B; Boche D; Perry VH; Gomez-Nicola D
    Brain Behav Immun; 2016 Jul; 55():179-190. PubMed ID: 26541819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype.
    Li H; Knight WC; Yang P; Guo Y; Perlmutter JS; Morris JC; Bateman RJ; Benzinger TLS; Xu J
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning.
    Eckenweber F; Medina-Luque J; Blume T; Sacher C; Biechele G; Wind K; Deussing M; Briel N; Lindner S; Boening G; von Ungern-Sternberg B; Unterrainer M; Albert NL; Zwergal A; Levin J; Bartenstein P; Cumming P; Rominger A; Höglinger GU; Herms J; Brendel M
    J Neuroinflammation; 2020 Jul; 17(1):208. PubMed ID: 32660586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
    Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
    Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.